KCNJ11, ABCC8 and TCF7L2 polymorphisms and the response to sulfonylurea treatment in patients with type 2 diabetes: a bioinformatics assessment

BACKGROUND: Type 2 diabetes (T2D) is a worldwide epidemic with considerable health and economic consequences. Sulfonylureas are widely used drugs for the treatment of patients with T2D. KCNJ11 and ABCC8 encode the K(ir)6.2 (pore-forming subunit) and SUR1 (regulatory subunit that binds to sulfonylure...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Jingwen, Yang, Yunzhong, Mauvais-Jarvis, Franck, Wang, Yu-Ping, Niu, Tianhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5461698/
https://www.ncbi.nlm.nih.gov/pubmed/28587604
http://dx.doi.org/10.1186/s12881-017-0422-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5461698/
https://www.ncbi.nlm.nih.gov/pubmed/28587604
http://dx.doi.org/10.1186/s12881-017-0422-7

Ejemplares similares